Haoxi Health Technology Limited (HAO)
| Market Cap | 2.85M -27.4% |
| Revenue (ttm) | 42.68M -12.9% |
| Net Income | -2.77M |
| EPS | -98.04 |
| Shares Out | 2.16M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 552,336 |
| Open | 1.350 |
| Previous Close | 1.540 |
| Day's Range | 1.220 - 1.350 |
| 52-Week Range | 1.220 - 295.680 |
| Beta | -0.57 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Apr 22, 2026 |
About HAO
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, a... [Read more]
Financial Performance
In fiscal year 2025, Haoxi Health Technology's revenue was $32.80 million, a decrease of -32.39% compared to the previous year's $48.52 million. Earnings were $3.88 million, an increase of 200.13%.
Financial StatementsNews
Haoxi Health Technology Ltd trading halted, news pending
19:50 EDT Haoxi Health Technology (HAO) Ltd trading halted, news pending
Haoxi Health Technology announces 1-for-128 reverse share split
Haoxi Health Technology (HAO) announced that it will effect a reverse share split of its outstanding Class A ordinary shares and Class B ordinary shares at a ratio of 1-for-128.
Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split
BEIJING, May 19, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ: HAO; “we” or the “Company”), today announced that it will effect a reverse share split of its outstanding Class A ord...
Univest Securities, LLC Announces Closing of $6.5 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)
New York, May 12, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, toda...
Haoxi Health Technology announces $6.5M registered direct offering
Haoxi Health Technology (HAO) announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of approximately $6.5M of the company’s…
Haoxi Health Technology Ltd Announces $6.5 Million Registered Direct Offering
BEIJING, May 11, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Ltd (NASDAQ: HAO) (“Haoxi” or the “Company”) today announced that it has entered into a definitive agreement with certain investors fo...
Haoxi Health, Eaglepoint AI forge strategic partnership
Haoxi Health Technology (HAO) and Eaglepoint AI, a subsidiary of Global Mofy AI Limited (GMM), jointly announced the signing of a three-year strategic cooperation agreement. The two parties will joint...
Haoxi Health Technology Registration statement: Registration Filing
Haoxi Health Technology filed a registration statement on June 10, 2025, providing details about a securities offering with the SEC.
Haoxi Health Technology files $80M mixed securities shelf
16:24 EDT Haoxi Health Technology (HAO) files $80M mixed securities shelf
Haoxi Health Technology Registration statement: Registration Filing
Haoxi Health Technology filed a registration statement on May 30, 2025, providing details about a securities offering with the SEC.
Haoxi Health Technology launches customized livestreaming agency strategy
Haoxi Health Technology (HAO) announced that Beijing Haoxi Digital Technology has launched its customized livestreaming agency strategy and is progressing partnership discussions on personalized lives...
Haoxi Health Technology Limited Launches Customized Livestreaming Agency Strategy
BEIJING, April 21, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, announced that Beijing Haox...
Haoxi Health Technology regains compliance with Nasdaq closing bid price rule
Haoxi Health Technology (HAO) received a formal notification from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires th...
Haoxi Health Technology Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
BEIJING, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that it rece...
Haoxi Health Technology Ltd trading halted, news pending
19:50 EST Haoxi Health Technology (HAO) Ltd trading halted, news pending
Haoxi Health Technology announces 1-for-25 reverse share split
Haoxi Health Technology (HAO) has resolved to effect a reverse share split of the Company’s ordinary shares, with the split ratio set at 1-for-25. The Reverse Share Split was approved…
Haoxi Health Technology Limited Announces 1-for-25 Reverse Share Split
BEIJING, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that it has ...
Haoxi Health Technology Transcript: AGM 2025
The AGM covered share consolidation, capital reorganization, amendments to governance documents, director re-elections, and auditor appointments. All seven resolutions passed with overwhelming shareholder approval.
Haoxi Health Technology awarded RMB30M framework contract
Haoxi Health Technology (HAO) announced the Company’s wholly owned subsidiary Beijing Haoxi Digital Technology was awarded a Recharge Service Framework Contract to provide comprehensive digital advert...
Haoxi Health Technology Limited Awarded a RMB30 Milllion Framework Contract to Provide Digital Advertising Services for Tengyuan Media Advertising Co., Ltd.
BEIJING, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced the Company'...
Haoxi Health Technology receives noncompliance letter from Nasdaq
Haoxi Health Technology (HAO) announced that the company received a letter from the Nasdaq, notifying the Company that it is not in compliance with the minimum bid price requirement set…
Haoxi Health Technology reports FY24 EPS 4c vs. 4c last year
Reports revenue $48.5M vs. $28.2M last year. Zhen Fan, CEO, stated that, “HAO has experienced financial growth in the fiscal year ended June 30, 2024, with net revenue increasing from…
Haoxi Health Technology Limited Reports Financial Results for Fiscal Year Ended June 30, 2024
BEIJING, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today reported its financial...
Haoxi Health Technology Annual report: Q4 2024
Haoxi Health Technology has published its Q4 2024 annual report on October 29, 2024.
Haoxi Health Technology sees FY24 revenue $48.52M vs. $28.23M last year
HAO projects revenue growth during FY24, which it attributes to the Company’s strategic development in online advertising solutions, particularly through short video formats and news feed ads. The Com...